Literature DB >> 25445424

Breast cancer in a RAD51D mutation carrier: case report and review of the literature.

Jennifer L Baker1, Richard B Schwab2, Anne M Wallace3, Lisa Madlensky4.   

Abstract

Entities:  

Keywords:  Cancer risk; Clinical trial; Genetic testing; Hereditary breast cancer; RAD51D

Mesh：

Substances：

Year:  2014        PMID： 25445424     DOI： 10.1016/j.clbc.2014.08.005

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  9 in total

1.  Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece.

Authors:  Irene Konstanta; Florentia Fostira; Paraskevi Apostolou; Efstratios Stratikos; Despoina Kalfakakou; Andreas Pampanos; Panagoula Kollia; Christos Papadimitriou; Irene Konstantopoulou; Drakoulis Yannoukakos
Journal:  J Hum Genet       Date:  2018-08-15       Impact factor: 3.172

2.  RNF138 interacts with RAD51D and is required for DNA interstrand crosslink repair and maintaining chromosome integrity.

Authors:  Brian D Yard; Nicole M Reilly; Michael K Bedenbaugh; Douglas L Pittman
Journal:  DNA Repair (Amst)       Date:  2016-04-21

3.  Metastatic Prostate Cancer in a RAD51C Mutation Carrier.

Authors:  Bindu R Potugari; Jessica M Engel; Adedayo A Onitilo
Journal:  Clin Med Res       Date:  2018-12

4.  Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.

Authors:  Lisa Golmard; Laurent Castéra; Sophie Krieger; Virginie Moncoutier; Khadija Abidallah; Henrique Tenreiro; Anthony Laugé; Julien Tarabeux; Gael A Millot; André Nicolas; Marick Laé; Caroline Abadie; Pascaline Berthet; Florence Polycarpe; Thierry Frébourg; Camille Elan; Antoine de Pauw; Marion Gauthier-Villars; Bruno Buecher; Marc-Henri Stern; Dominique Stoppa-Lyonnet; Dominique Vaur; Claude Houdayer
Journal:  Eur J Hum Genet       Date:  2017-11-08       Impact factor: 4.246

5.  Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.

Authors:  Takae Brewer; Lamis Yehia; Peter Bazeley; Charis Eng
Journal:  Am J Hum Genet       Date:  2022-08-04       Impact factor: 11.043

6.  DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.

Authors:  Marie Ollier; Nina Radosevic-Robin; Fabrice Kwiatkowski; Flora Ponelle; Sandrine Viala; Maud Privat; Nancy Uhrhammer; Dominique Bernard-Gallon; Frédérique Penault-Llorca; Yves-Jean Bignon; Yannick Bidet
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

Review 7.  Hereditary breast and ovarian cancer: new genes in confined pathways.

Authors:  Finn Cilius Nielsen; Thomas van Overeem Hansen; Claus Storgaard Sørensen
Journal:  Nat Rev Cancer       Date:  2016-08-12       Impact factor: 60.716

8.  Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic.

Authors:  Marketa Janatova; Jana Soukupova; Jana Stribrna; Petra Kleiblova; Michal Vocka; Petra Boudova; Zdenek Kleibl; Petr Pohlreich
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

9.  Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma.

Authors:  Yan-Ji Jiang; Jian-Hong Zhong; Zi-Han Zhou; Mo-Qin Qiu; Xian-Guo Zhou; Ying-Chun Liu; Rong-Rui Huo; Xiu-Mei Liang; Zhu Chen; Qiu-Ling Lin; Xiang-Yuan Yu; Hong-Ping Yu
Journal:  Cancer Med       Date:  2019-03-18       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.